智通财经APP获悉，复宏汉霖(02696)涨超5%，截至发稿，涨4.7%，报70.15港元，成交额1635万港元。
消息面上，据复宏汉霖官微消息，ESMO ASIA 2025将于12月5日~12月7日在新加坡召开。会上，复宏汉霖将携4款产品，包括HLX43(PD-L1 ADC)、H药 汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)、HLX11(帕妥珠单抗生物类似药，美国商品名：POHERDY®)及HLX78(拉索昔芬片)的10项最新研究数据亮相大会，以优选论文口头报告、小型口头报告及壁报等形式展示公司在肿瘤治疗领域的多元化布局与前沿探索，印证多元创新平台实力。其中，广谱抗肿瘤ADC HLX43在宫颈癌领域的II期临床数据将在大会上首次发布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.